Last update 20 Dec 2025

DYRK inhibitors(Carna Biosciences)

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms-
Target
DYRK
Action
inhibitors
Mechanism
DYRK inhibitors(DYRK kinase inhibitors)
Therapeutic Areas
NeoplasmsNervous System DiseasesEndocrinology and Metabolic Disease
Active Indication
DementiaDepressive DisorderEpilepsy+ [2]
Inactive Indication-
Originator Organization
Carna Biosciences, Inc.Carna Biosciences, Inc.
Active Organization
Carna Biosciences, Inc.Carna Biosciences, Inc.Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePreclinical
First Approval Date-
Regulation-

Related

100 Clinical Results associated with DYRK inhibitors(Carna Biosciences)
Login to view more data
100 Translational Medicine associated with DYRK inhibitors(Carna Biosciences)
Login to view more data
100 Patents (Medical) associated with DYRK inhibitors(Carna Biosciences)
Login to view more data
100 Deals associated with DYRK inhibitors(Carna Biosciences)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
DementiaPreclinical
Japan
Carna Biosciences, Inc.Carna Biosciences, Inc.
23 Feb 2023
DementiaPreclinical
Japan
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
23 Feb 2023
Depressive DisorderPreclinical
Japan
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
23 Feb 2023
Depressive DisorderPreclinical
Japan
Carna Biosciences, Inc.Carna Biosciences, Inc.
23 Feb 2023
EpilepsyPreclinical
Japan
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
23 Feb 2023
EpilepsyPreclinical
Japan
Carna Biosciences, Inc.Carna Biosciences, Inc.
23 Feb 2023
NeoplasmsPreclinical
Japan
Carna Biosciences, Inc.Carna Biosciences, Inc.
23 Feb 2023
NeoplasmsPreclinical
Japan
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
23 Feb 2023
Thyroid DiseasesPreclinical
Japan
Sumitomo Pharma Co., Ltd.Sumitomo Pharma Co., Ltd.
23 Feb 2023
Thyroid DiseasesPreclinical
Japan
Carna Biosciences, Inc.Carna Biosciences, Inc.
23 Feb 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free